Q3 2023 Holdings
Filed 2023-11-13 | 80 holdings | $329.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sprd S&P Biotech ETF(XBI)Call | LONG OPTION CALLS | 78464A870 | $21.9M | 300,000 | 6.6% |
| ImmunoGen Inc(IMGNEUR) | EQUITIES | 45253H101 | $20.7M | 1,307,435 | 6.3% |
| Morphic Holding Inc | EQUITIES | 61775R105 | $13.5M | 590,829 | 4.1% |
| Merus NV | EQUITIES | N5749R100 | $11.8M | 500,000 | 3.6% |
| Soleno Therapeutics Inc(SLNO) | EQUITIES | 834203309 | $10.9M | 370,000 | 3.3% |
| Intra-Cellular Therapies Inc(ITCIEUR) | EQUITIES | 46116X101 | $10.9M | 208,730 | 3.3% |
| Akero Therapeutics Inc(AKRO)Call | LONG OPTION CALLS | 00973Y108 | $10.1M | 200,000 | 3.1% |
| CymaBay Therapeutics Inc(CBAYUSD) | EQUITIES | 23257D103 | $8.8M | 590,000 | 2.7% |
| Mirati Therapeutics Inc(MRTXEUR) | EQUITIES | 60468T105 | $8.7M | 200,000 | 2.6% |
| Poseida Therapeutics Inc(PSTXUSD) | EQUITIES | 73730P108 | $8.5M | 3,567,985 | 2.6% |
| Krystal Biotech Inc(KRYS) | EQUITIES | 501147102 | $8.3M | 71,531 | 2.5% |
| Biogen Idec Inc(BIIB) | EQUITIES | 09062X103 | $7.2M | 28,069 | 2.2% |
| Urogen Pharma Ltd(URGN) | EQUITIES | M96088105 | $7.1M | 508,883 | 2.2% |
| United Therapeutics Corp(UTHR) | EQUITIES | 91307C102 | $7.1M | 31,424 | 2.2% |
| Praxis Precision Medicines Inc | EQUITIES | 74006W108 | $7.0M | 4,117,920 | 2.1% |
| Oric Pharmaceuticals Inc(ORIC) | EQUITIES | 68622P109 | $6.8M | 1,123,345 | 2.1% |
| Crinetics Pharmaceuticals Inc(CRNX) | EQUITIES | 22663K107 | $6.5M | 220,000 | 2.0% |
| Mirati Therapeutics Inc(MRTXEUR)Call | LONG OPTION CALLS | 60468T105 | $6.5M | 150,000 | 2.0% |
| Cogent Biosciences Inc(COGT) | EQUITIES | 19240Q201 | $6.4M | 651,372 | 1.9% |
| Mersana Therapeutics Inc | EQUITIES | 59045L106 | $6.4M | 5,000,000 | 1.9% |
| Rhythm Pharmaceuticals Inc(RYTM) | EQUITIES | 76243J105 | $6.0M | 260,537 | 1.8% |
| MacroGenics Inc(MGNX) | EQUITIES | 556099109 | $5.9M | 1,264,158 | 1.8% |
| BioCryst Pharmaceuticals Inc(BCRX) | EQUITIES | 09058V103 | $5.6M | 791,671 | 1.7% |
| Novo Nordisk A/S(NVO) | EQUITIES | 670100205 | $5.5M | 60,000 | 1.7% |
| Akero Therapeutics Inc(AKRO)Put | LONG OPTION PUTS | 00973Y108 | $5.4M | 106,600 | 1.6% |
| Veracyte Inc(VCYT) | EQUITIES | 92337F107 | $5.3M | 239,571 | 1.6% |
| KalVista Pharmaceuticals Inc(KALV)Call | LONG OPTION CALLS | 483497103 | $5.1M | 530,400 | 1.5% |
| Gossamer Bio Inc(GOSS) | EQUITIES | 38341P102 | $5.1M | 6,130,268 | 1.5% |
| Olema Pharmaceuticals Inc(OLMA) | EQUITIES | 68062P106 | $5.0M | 407,801 | 1.5% |
| Humana Inc(HUM) | EQUITIES | 444859102 | $4.9M | 10,000 | 1.5% |
| Vertex Pharmaceuticals Inc(VRTX) | EQUITIES | 92532F100 | $4.8M | 13,765 | 1.5% |
| Gilead Sciences Inc(GILD) | EQUITIES | 375558103 | $4.7M | 62,789 | 1.4% |
| Pliant Therapeutics Inc(PLRX) | EQUITIES | 729139105 | $4.3M | 250,409 | 1.3% |
| Caribou Biosciences Inc(CRBU) | EQUITIES | 142038108 | $4.3M | 892,786 | 1.3% |
| ImmunoGen Inc(IMGNEUR)Call | LONG OPTION CALLS | 45253H101 | $4.0M | 250,000 | 1.2% |
| Tela Bio Inc(TELA) | EQUITIES | 872381108 | $3.9M | 490,471 | 1.2% |
| Insmed Inc(INSM) | EQUITIES | 457669307 | $3.8M | 150,387 | 1.2% |
| Mirum Pharmaceuticals Inc(MIRM) | EQUITIES | 604749101 | $3.5M | 110,114 | 1.1% |
| CymaBay Therapeutics Inc(CBAYUSD)Call | LONG OPTION CALLS | 23257D103 | $3.0M | 200,000 | 0.9% |
| Reviva Pharmaceuticals Holdings Inc(RVPH)Put | LONG OPTION PUTS | 76152G100 | $2.8M | 564,000 | 0.8% |
| Zura Bio Ltd(ZURA) | EQUITIES | G9TY5A101 | $2.7M | 404,040 | 0.8% |
| Terns Pharmaceuticals Inc(TERN) | EQUITIES | 880881107 | $2.5M | 500,000 | 0.8% |
| Molecular Templates Inc | EQUITIES | 608550208 | $2.2M | 354,608 | 0.7% |
| KalVista Pharmaceuticals Inc(KALV) | EQUITIES | 483497103 | $2.2M | 228,934 | 0.7% |
| Trevi Therapeutics Inc(TRVI) | EQUITIES | 89532M101 | $2.0M | 927,415 | 0.6% |
| Kodiak Sciences Inc(KOD) | EQUITIES | 50015M109 | $2.0M | 1,114,461 | 0.6% |
| Cerus Corp(CERS) | EQUITIES | 157085101 | $2.0M | 1,203,890 | 0.6% |
| Xenon Pharmaceuticals Inc(XENE) | EQUITIES | 98420N105 | $1.8M | 53,996 | 0.6% |
| Evogene Ltd(EVGN) | EQUITIES | M4119S104 | $1.8M | 3,100,000 | 0.6% |
| Intellia Therapeutics Inc(NTLA) | EQUITIES | 45826J105 | $1.7M | 53,018 | 0.5% |